HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Li, X.-M. Articles by Sampson, H. A. Search for Related Content PubMed PubMed Citation Articles by Li, X.-M. Articles by Sampson, H. A. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB HISTAMINE

Engineered Recombinant Peanut Protein and Heat-Killed Listeria monocytogenes Coadministration Protects Against Peanut-Induced Anaphylaxis in a Murine Model¹

Xiu-Min Li^2,*, Kamal Srivastava^*, James W. Huleatt, Kim Bottomly, A. Wesley Burks and Hugh A. Sampson^*

^* Department of Pediatrics, Mount Sinai School of Medicine, New York, NY 10029; Section of Immunology, Yale University School of Medicine, New Haven, CT 06520; and Department of Pediatrics, Arkansas Children’s Hospital Research Institute, University of Arkansas, Little Rock, AR 72205

Peanut allergy (PNA) is the major cause of fatal and near-fatal anaphylactic reactions to foods. Traditional immunotherapy using peanut (PN) protein is not an option for PNA therapy because of the high incidence of adverse reactions. We investigated the effects of s.c. injections of engineered (modified) recombinant PN proteins and heat-killed Listeria monocytogenes (HKLM) as an adjuvant on anaphylactic reactions in a mouse model of PN allergy. PN-allergic C3H/HeJ mice were treated s.c. with a mixture of the three major PN allergens and HKLM (modified (m)Ara h 1–3 plus HKLM). The effects on anaphylactic reactions following PN challenge and the association with Ab levels and cytokine profiles were determined. Although all mice in the sham-treated groups exhibited anaphylactic symptoms with a median symptom score of 3, only 31% of mice in the mAra h 1–3 plus HKLM group developed mild anaphylaxis, with a low median symptom score of 0.5. Alterations in core body temperature, bronchial constriction, plasma histamine, and PN-specific IgE levels were all significantly reduced. This protective effect was markedly more potent than in the mAra h 1–3 protein alone-treated group. HKLM alone did not have any protective effect. Reduced IL-5 and IL-13, and increased IFN- levels were observed only in splenocytes cultures from mAra h 1–3 plus HKLM-treated mice. These results show that immunotherapy with modified PN proteins and HKLM is effective for treating PN allergy in this model, and may be a potential approach for treating PNA.

This article has been cited by other articles:

				H. R. Jang, M. T. Gandolfo, G. J. Ko, S. Satpute, L. Racusen, and H. Rabb Early exposure to germs modifies kidney damage and inflammation after experimental ischemia-reperfusion injury Am J Physiol Renal Physiol, November 1, 2009; 297(5): F1457 - F1465. [Abstract] [Full Text] [PDF]

				J. Sun, K. Arias, D. Alvarez, R. Fattouh, T. Walker, S. Goncharova, B. Kim, S. Waserman, J. Reed, A. J. Coyle, et al. Impact of CD40 Ligand, B Cells, and Mast Cells in Peanut-Induced Anaphylactic Responses J. Immunol., November 15, 2007; 179(10): 6696 - 6703. [Abstract] [Full Text] [PDF]

				R. Fischer, J. R. McGhee, H. L. Vu, T. P. Atkinson, R. J. Jackson, D. Tome, and P. N. Boyaka Oral and Nasal Sensitization Promote Distinct Immune Responses and Lung Reactivity in a Mouse Model of Peanut Allergy Am. J. Pathol., December 1, 2005; 167(6): 1621 - 1630. [Abstract] [Full Text] [PDF]